Keywords:
Carcinoma in situ
Carcinoma in situ
Cite
Citations (1)
Carcinoma in situ
Grading (engineering)
Lobular carcinoma
Cite
Citations (3)
Carcinoma in situ
Grading (engineering)
Lobular carcinoma
Cite
Citations (0)
Carcinoma in situ
Cite
Citations (29)
Carcinoma in situ
Cite
Citations (30)
Statistics from the Connecticut Tumor Registry from 1979 to 1988 were examined, and individual medical records from 1979 to 1983 were also reviewed. Three hundred nineteen medical records were available for review, documenting 220 cases of ductal carcinoma in situ and 102 cases of lobular carcinoma in situ. In 1979, there were 33 new cases of ductal carcinoma in situ reported to the Connecticut Tumor Registry, representing 1.8% of all breast cancers. There has been a yearly increase in ductal carcinoma in situ, with 200 new cases, or 7.4% of all breast cancers, reported in 1988. Forty-eight (22%) of 217 patients with ductal carcinoma in situ had bilateral breast involvement with ductal carcinoma in situ or an invasive breast cancer. Ten (83%) of 12 mastectomy specimens from patients with ductal carcinoma in situ who presented with nipple discharge demonstrated residual tumor, suggesting a more diffuse involvement. Two of the three reported recurrences involved nipple discharge. Thirty-seven (16.8%) of the 220 patients with ductal carcinoma in situ and six (5.9%) of the 102 patients with lobular carcinoma in situ were diagnosed as having another unrelated cancer. Ongoing clinical trials will direct optimum therapy for patients increasingly diagnosed as having ductal carcinoma in situ.
Lobular carcinoma
Carcinoma in situ
Cite
Citations (36)
Nuclear pleomorphism is a fundamental feature in evaluating the aggressiveness of ductal carcinoma in situ (DCIS) of the breast. In this study, pure DCIS and the in situ component (IS-comp) of invasive duct carcinoma (IDC) are compared in order to verify if these are two different entities or the same process observed at different times during its evolution. Five cases of pure DCIS and nine of IDC with extensive in situ component were selected. They were moderately and poorly differentiated. 30 nuclei for each DCIS, and 30 nuclei for both the in situ and invasive component of each IDC were studied; thus, a total of 720 nuclei were submitted to the SAM (Shape Analytical Morphometry) analysis, which enables a numerical expression not only of dimensions (area, perimeter, diameter) but also of nuclear contour irregularities and nuclear shape distortions. Univariate statistical comparisons were carried out between the nuclei of: (1) DCIS and in situ component of invasive duct carcinoma, (2) DCIS and the invasive component of infiltrating carcinoma and (3) between the in situ and invasive component of infiltrating carcinoma. Multivariate analysis was utilized to compare nuclei of DCIS with the in situ component of IDC. The in situ features of each tumor were also evaluated with the mitotic index (MI). Nuclei of pure DCIS resulted significantly larger (p < 0.001) and with a more regular shape (p < 0.001) than those of the in situ component of IDC. No differences were observed between the nuclei of the in situ and the invasive component of infiltrating carcinomas. Multivariate statistical analysis discriminated 77% of nuclei of in situ proliferation when both G2 and G3 tumors were considered, and 80% when only G3 tumors were considered. In conclusions morphological differences exist between pure DCIS and the in situ component of IDC, which may be an expression of their biological behavior; moreover, these morphological differences seem to have a better discriminating power within the same histological grade.
Carcinoma in situ
Cite
Citations (14)
A series of 81 cases of severe dysplasia or carcinoma in situ of the larynx was retrospectively analysed to evaluate the results of radiation therapy and repetitive stripping/biopsies. An average of almost five years elapsed between the diagnosis of severe dysplasia/carcinoma in situ and carcinoma. Of patients primarily treated with irradiation 19% developed invasive carcinoma compared to 15% in the group primarily treated with repetitive stripping/biopsies, and radiation therapy for failures. The mean age at diagnosis for patients in whom the epithelium normalized was 66.1 years, compared to 59.3 years for those in whom the process progressed to carcinoma (p less than 0.05). It thus appears that carcinoma in situ may comprise at least two different lesions with different biological behaviour.
Carcinoma in situ
Cite
Citations (30)
We have illustrated intraductal papillomas that have a variety of alterations not found in "ordinary" or typical papillomas. Many of these changes are indistinguishable from ductal carcinoma in situ. A priori, one might expect that patients with papillomas associated with changes identical to ductal carcinoma in situ would be at an increased risk for subsequent invasive carcinoma. We suspect that there is an increased risk based on the fact that seven of our 26 cases (27 percent) had fully diagnostic ductal carcinoma in situ or invasive carcinoma in the breast. However, the degree of increased risk has not been definitely established.
Carcinoma in situ
Intraductal papilloma
Atypical Hyperplasia
Cite
Citations (4)
The outcome of 75 patients with severe dysplasia or carcinoma in situ of the larynx has been reviewed. The patients were divided into three groups according to treatment; Group A (16 patients) had received irradiation. Group B (24 patients) had developed invasive carcinoma less than 1 year after the diagnosis of carcinoma in situ and Group C (41 patients) had been observed for more than 1 year, receiving no treatment other than repeat biopsies. Of the latter group, 46% developed invasive carcinoma of the vocal cords, with a mean observation time of 51 months. Mean age at the onset of the disease was 66 years in patients where the epithelium returned macroscopically to normal during observation compared to 59 years in patients who developed carcinoma (P less than 0.05). This may indicate that subgroups of carcinoma in situ exist with different biological behaviour. No extra benefit was seen for the patients who received irradiation for carcinoma in situ, and close follow-up with, eventually, stripping of the epithelium is therefore advocated. Both altered anatomical site during observation and an increase in area of the lesion should be regarded as a warning signal.
Carcinoma in situ
Cite
Citations (26)